ClinicalTrials.Veeva

Menu
H

Hospital Aleman | Department of Cardiology Service

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Carfilzomib
Bemarituzumab
BGB-11417
CC-99282

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma a...

Enrolling
Lymphoma, Non-Hodgkin
Drug: CC-99282
Drug: Tafasitamab

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Enrolling
Solid Tumors
Drug: Bemarituzumab

The study consists of two parts. Part 1 determines the safety and tolerability of BGB-11417 (sonrotoclax) monotherapy, the maximum tolerated dose, an...

Enrolling
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

The purpose of Phase 1b of this study is to:* Asses the safety, tolerability and activity of carfilzomib, alone and in combination with induction che...

Active, not recruiting
Acute Lymphoblastic Leukemia (ALL)
Drug: Vincristine
Drug: Intrathecal (IT) Methotrexate

Trial sponsors

Amgen logo
BeiGene logo
Celgene logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems